| Methods |
Randomised
Controlled
Trial |
| Participants |
Country:
Germany
Mean age: 47
% Female: 51
Disease duration: NR
Duration: 1 y
Number randomised: 111
(HA 56, O2 53)
Inclusion: NR
Exclusion: NR
Baseline values:
Rest pain:
GF: 29.03
O2: 28.89
Movement pain:
GF: 58.57
O2: 47.40
WOMAC Pain
GF: 8.2
O2: 6.8
WOMAC Function
GF: 22.5
O2: 20.6
WOMAC Stiffness:
GF: 2.7
O2: 2.7 |
| Interventions |
Hylan G‐F 20 3 weekly injections + exercise programme,
IA gaseous oxygen + exercise programme |
| Outcomes |
Pain at rest and under strain (100 mm VAS),
WOMAC OA Index,
Lysholm score,
Tegner Activity Index |
| Notes |
Jadad's:2/5
R‐1,B‐0,W‐1 |
| Risk of bias |
| Bias |
Authors' judgement |
Support for judgement |
| Allocation concealment (selection bias) |
Unclear risk |
B ‐ Unclear |
